Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 1
2006 3
2007 5
2008 6
2009 3
2010 2
2011 4
2012 6
2013 2
2014 9
2015 15
2016 14
2017 8
2018 8
2019 4
2020 11
2021 10
2022 17
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Koblish HK, Wu L, Wang LS, Liu PCC, Wynn R, Rios-Doria J, Spitz S, Liu H, Volgina A, Zolotarjova N, Kapilashrami K, Behshad E, Covington M, Yang YO, Li J, Diamond S, Soloviev M, O'Hayer K, Rubin S, Kanellopoulou C, Yang G, Rupar M, DiMatteo D, Lin L, Stevens C, Zhang Y, Thekkat P, Geschwindt R, Marando C, Yeleswaram S, Jackson J, Scherle P, Huber R, Yao W, Hollis G. Koblish HK, et al. Among authors: yao w. Cancer Discov. 2022 Jun 2;12(6):1482-1499. doi: 10.1158/2159-8290.CD-21-1156. Cancer Discov. 2022. PMID: 35254416 Free PMC article. Clinical Trial.
Ultratough Hydrogen-Bond-Bridged Phosphorene Films.
Liu Z, Wang H, Cao H, Xie D, Li C, Yang H, Yao W, Cheetham AK. Liu Z, et al. Among authors: yao w. Adv Mater. 2022 Sep;34(39):e2203332. doi: 10.1002/adma.202203332. Epub 2022 Aug 26. Adv Mater. 2022. PMID: 35929459
Inhibition of ALK2 with bicyclic pyridyllactams.
Witten MR, Wu L, Lai CT, Kapilashrami K, Pusey M, Gallagher K, Chen Y, Yao W. Witten MR, et al. Among authors: yao w. Bioorg Med Chem Lett. 2022 Jan 1;55:128452. doi: 10.1016/j.bmcl.2021.128452. Epub 2021 Nov 13. Bioorg Med Chem Lett. 2022. PMID: 34780900
Electron Spin Catalysis with Graphene Belts.
Tian Y, Cao H, Yang H, Yao W, Wang J, Qiao Z, Cheetham AK. Tian Y, et al. Among authors: yao w. Angew Chem Int Ed Engl. 2023 Mar 1;62(10):e202215295. doi: 10.1002/anie.202215295. Epub 2023 Jan 31. Angew Chem Int Ed Engl. 2023. PMID: 36617498
Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream.
Smith P, Yao W, Shepard S, Covington M, Lee J, Lofland J, Naim A, Sheth T, Parikh B, Yeleswaram S. Smith P, et al. Among authors: yao w. Pharmaceutics. 2021 Jul 8;13(7):1044. doi: 10.3390/pharmaceutics13071044. Pharmaceutics. 2021. PMID: 34371735 Free PMC article. Review.
Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors.
Ye Q, Liu K, Ye HF, Pan J, Sokolsky A, Wang A, Zhang K, Hummel JR, Kong L, Behshad E, He X, Conlen P, Stump K, Ye M, Diamond S, Covington M, Yeleswaram S, Atasoylu O, Vechorkin O, Yao W. Ye Q, et al. Among authors: yao w. ACS Med Chem Lett. 2022 Dec 12;14(1):5-10. doi: 10.1021/acsmedchemlett.2c00238. eCollection 2023 Jan 12. ACS Med Chem Lett. 2022. PMID: 36655125 Free PMC article.
Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors.
Sokolsky A, Winterton S, Kennedy K, Drake K, Stump K, Huo L, Lo Y, Ye M, Covington M, Diamond S, Yang YO, Kim S, Yeleswaram S, Wu L, Yao W. Sokolsky A, et al. Among authors: yao w. ACS Med Chem Lett. 2022 Oct 6;13(11):1797-1804. doi: 10.1021/acsmedchemlett.2c00408. eCollection 2022 Nov 10. ACS Med Chem Lett. 2022. PMID: 36385925 Free PMC article.
Targeting MEK in vemurafenib-resistant hairy cell leukemia.
Caeser R, Collord G, Yao WQ, Chen Z, Vassiliou GS, Beer PA, Du MQ, Scott MA, Follows GA, Hodson DJ. Caeser R, et al. Leukemia. 2019 Feb;33(2):541-545. doi: 10.1038/s41375-018-0270-2. Epub 2018 Oct 19. Leukemia. 2019. PMID: 30341394 Free PMC article. No abstract available.
124 results